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The microbial pattern-recognizing Toll-like receptors (TLRs) play an essential role in 
shaping the expansion and maturation of the postnatal intestinal epithelium as well as 
transducing signals from luminal flora to the host. Notably, disruption of this intestinal 
homeostasis regulated by TLRs affects epithelial cell growth and thus cancer development. 
To assess the role of TLR4 signalling in epithelial cell proliferation and intestinal 
homeostasis, we generated a transgenic mouse strain carrying a constitutively active TLR4 
(CD4-TLR4) that is linked to an intestinal epithelial cell-specific promoter. CD4-TLR4 
transgenic mice had normal intestinal morphology but displayed enhanced Paneth cell 
functions. Interestingly, crypt-villus organoid cultures derived from CD4-TLR4 mice 
displayed increased proliferative capacity whilst Cox-2 expression was surprisingly reduced 
as compared to organoids from non-transgenic, wild-type mice. Introduction of the CD4-
TLR4 transgene into APCMin/+ mice, a model of colorectal carcinoma, resulted in a dramatic 
drop in tumor load in contrast to wild-type APCMin/+ mice. Furthermore, down-regulation of 
Cox-2 protein, coincident with elevated IFNβ expression, resulted in increased levels of 
apoptosis in CD4-TLR4-APCMin/+ intestinal tumors in vivo. Thus, triggering of microbial 
signalling via TLR4, at the onset of epithelial cell differentiation, can guide development of 







Toll-like receptors (TLRs) are a family of pattern recognition receptors known to 
regulate host defence against infection, intestinal homeostasis and mucosal innate immune 
functions. Through their ability to recognize pathogen-associated molecular patterns 
(PAMPs) found on microbes, TLRs transduce signals from the luminal surface to the 
intestinal mucosal layer. One major TLR involved in the sensing of gram-negative enteric 
bacteria and their products such as lipopolysaccharide (LPS) is TLR4. Several studies 
involving a variety of microbial products and TLR4 agonists have implicated the critical role 
of TLR4 signalling in the regulation of tumor growth, survival and progression.  
In the APCMin/+ mouse model of spontaneous intestinal tumorigenesis, genetic 
ablation of MyD88, a downstream signalling adaptor of TLRs, resulted in the reduction of 
small intestinal tumor frequency and size [1]. This finding thus suggests the potential role of 
microbial signalling, of which the TLR4 cascade is a major component, in promoting 
intestinal tumorigenesis, via the MyD88-dependent signalling pathway. Further evidence 
supporting the positive role of TLR4 in cancer development was demonstrated in a variety of 
adoptively transferred tumors, where LPS was found to augment tumor growth and 
metastasis [2, 3, 4].  
While TLR4 signalling has been shown to drive tumorigenesis, recent accumulating 
evidence has also pointed to an anti-tumor effect of TLR4 activation. Potent anti-cancer 
effects against adoptively transferred tumors in mice have been illustrated with the 
administration of LPS [5, 6]. Moreover, the administration of LPS and two other potent 
TLR4 agonists, OK-432 and Mycobacterium bovis bacillus Calmette-Guérin (BCG), have 
been shown to be effective in the treatment of various carcinomas such as colorectal, gastric, 
bladder and lung cancer [7, 8, 9, 10]. This negative regulatory role of TLR4 in cancer 
recapitulates the earlier work by William Coley in the 19th century, where repeated injections 
of bacterial toxins, later found to be LPS, was effective as an anti-cancer therapeutic [11].  
Thus, the role of TLR4 signalling in tumor development is complex and warrants further 
investigation.  
One major mediator of tumor growth and survival is cyclooxygenase 2 (Cox-2). 
Cyclooxygenases, also known as prostaglandin-endoperoxide synthases (PTGS), are 
important enzymes that catalyze the synthesis of prostaglandins (PGs) from arachidonic acid 
[12]. To date, there are two known isoforms of cyclooxgenases, Cox-1 and Cox-2, which are 
4 
 
differentially expressed and regulated. In contrast to Cox-1, which is expressed ubiquitously 
in most tissues and generally considered to contribute to cellular homeostasis, Cox-2 
expression is rapidly induced by inflammatory mediators, growth factors, oncogenes and 
endotoxins [12]. Cox-2 is a known critical player of cancer progression in various aspects, 
including cell proliferation and migration, apoptosis, tumor angiogenesis and metastasis [13, 
14]. In the context of colorectal cancer, usage of Cox-2 inhibitors has been efficacious in the 
treatment of familial adenomatous polyposis (FAP) patients [15, 16]. 
Our recent work as well as studies by other groups has highlighted the crucial role of TLR4 
stimulation in promoting tumor cell proliferation and survival in vitro [17, 18, 19]. Thus in 
this current study, we were interested to understand how TLR4 signalling influences 
intestinal homeostasis in vivo, in particular, the development of intestinal tumors arising from 
a genetic predisposition such as the APCMin/+ mouse model [20]. In our investigation, we 
developed APCMin/+ mice expressing constitutively active TLR4 (CD4-TLR4) specifically in 
the intestinal epithelium. Interestingly, CD4-TLR4 expressing APCMin/+ mice displayed 
reduced tumor burden in the intestine, and their small intestinal tumors showed increased 
apoptosis in vivo that correlate with Cox-2 down-regulation. Our findings thus shed light on 
an unrecognized role of long-term epithelial TLR4 activation in the inhibition of 




Materials and methods 
 
Animal studies 
CD4-TLR4 transgenic mice were generated using the mCD4-TLR4 fusion gene (a gift from 
Dr Medzhitov) [21], which comprises a constitutively active human TLR4 cytoplasmic 
domain fused to the extracellular domain of murine CD4, under the control of intestinal 
epithelial cell-specific fatty acid binding (I-FABP) promoter in a similar procedure as 
described previously [22]. Verification of transgenic mice was performed by PCR 
amplification of genomic DNA using the following primers: 5’-CGCTTCAGTTTGCTG-3’, 
5’-CCGGGAATAAAGTCTCT-3’. Mice were backcrossed to C57BL/6 mice for over ten 
generations. To introduce APCMin/+ mutation, CD4-TLR4-positive females were paired with 
APCMin/+ males. Mice of the first generation derived from these crosses were used to assess 
tumorigenesis. For tumor counting, whole intestine was fixed in PBS-buffered 4% formalin 
solution and cut longitudinally. Only clearly defined adenomas exceeding 0.8 mm were 
counted as tumors under the dissection microscope. Mice were maintained under specific 
pathogen free conditions. All animal experiments were performed following Swedish ethical 
regulations and guidelines of the Institutional Animal Care and Use Committee of SingHealth 
Office of Research.  
Reverse-transcription PCR and quantitative real-time PCR 
 Total RNA from mucosal scrapings of different intestinal segments was extracted 
using the RNeasy mini kit (Qiagen) according to manufacturer’s instructions. 2µg total RNA 
was used for cDNA synthesis using Superscript II (Invitrogen). Transgene expression was 
analyzed via PCR amplification of 2.5 µl cDNA using primers specific for murine CD4 and 
human TLR4: 5’-GGTTCTGGCAACCTGACTCT-3’ and 5’-
CCCACTGTTCCTTCTGGATT-3’.  
Quantitative real-time PCR (qRT-PCR) was performed in triplicates for each sample 
on a ABI 7500 Real time PCR System (Applied Biosystems) using Fast SYBR Green PCR 
Mastermix (Applied Biosystems). Mouse primer sequences for the various genes described in 
the study are presented in Supplementary table 1. Q-PCR data are presented as fold change of 





 Colonic tissues from CD4-TLR4 and wild-type (WT) mice were freshly embedded in 
OCT (Tissue-Tek 4583), snap frozen and sectioned on a cryostat. Sections were blocked in 
10% mouse serum for 30 min at room temperature before incubating with CD4 antibody (BD 
Pharmingen, 550278) at 1:50 dilution for 1 h at room temperature. The slides were then 
washed in PBS and incubated with Alexa Fluor 488 goat anti-rat IgG (Invitrogen, A11006). 
4',6-diamidino-2-phenylindole (Dapi) was used for nuclear staining. For staining with Ki-67 
antibody (Leica, NCL-Ki-67-MM1), formalin-fixed intestinal tissues from CD4-TLR4 and 
wild-type (WT) mice were used. Sections were deparaffinised in Bond Dewax solution 
(Leica) before performing antigen retrieval using Bond Epitope Retrieval Solution (Leica).  
 
Crypt isolation, cell dissociation and culture 
 S1-3 small intestinal segments (refer to Figure S1B for classification) from CD4-
TLR4 and WT mice were collected for crypt isolation and culture as described previously 
[23]. 6000 crypts per well on 48-well plates were cultured as described previously [23]. For 
culture experiments, four independent experiments were performed. For each culture/sorting 
experiment, crypts were pooled from 2-5 intestines. At day 6 from initial plating of crypts, 
total RNA was isolated from cultures using Trizol LS reagent (Invitrogen) according to 
manufacturer’s recommendations. 
For sorting of Paneth cells, crypts were dissociated with 0.5X trypsin for 40 min at 
37ºC, passed through a 40 µm cell strainer (BD) and washed with PBS/2% FBS. Cells were 
incubated with anti-CD24 antibody (BD Pharmingen, 553260) for 50 min at 4ºC, washed 
with PBS/2% FBS and then incubated with Alexa-fluor goat anti-rat IgG for 30 min at 4ºC. 
Viable epithelial single cells were gated by forward scatter, side scatter and pulse-width 
parameter, and negative staining for dapi. Cells were collected in cold PBS containing 20% 
FBS, and total RNA was extracted using PicoPure RNA isolation kit (Arcturus) according to 
manufacturer’s instructions. 
 
In vivo apoptosis assay 
To detect apoptosis in vivo, CD4-TLR4-APCMin/+ and APCMin/+ mice were injected 
intravenously with FAM-FLIVO (Immunochemistry, 981) via tail vein 1 h prior to sacrifice 
and harvesting of intestinal tissues. Whole intestines were fixed in PBS-buffered 4% formalin 
solution and cut longitudinally. Tissues sections of tumors and normal epithelia were 
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subsequently made and apoptotic cells were visualized under a fluorescence microscope at an 
excitation wavelength of 488 nm. At least 10 different small intestinal tumors and 60 non-
overlapping microscopic fields of view under a 20X objective from each group were 
analyzed and counted for apoptotic cells.  
 
Statistical analysis 




Constitutive epithelial TLR4 signalling suppresses APCMin/+ intestinal tumorigenesis  
In our recent study of APCMin/+ mice, we established microbial signalling as a major 
mediator of intestinal tumorigenesis [17]. This finding complements previous work from 
Medzhitov’s group, whereby deletion of MyD88 resulted in a dramatic reduction of tumor 
burden in APCMin/+ mice [1]. Moreover, we further identified TLR4, a key component of 
microbial signalling, as a regulator of tumor cell proliferation [17].  We thus sought to further 
dissect its role in intestinal tumorigenesis in vivo. To address this, we generated mice 
transgenic for CD4-TLR4, which comprised of murine CD4 ectodomain fused to 
constitutively active domains of human TLR4 [21]. To avoid interference with the intestinal 
stem cell compartment, the CD4-TLR4 transgene was linked to the intestinal fatty acid 
binding protein (I-FABP) promoter, which is only expressed in mature epithelial lineages of 
the intestine [24, 25]. Analysis of various intestinal segments by RT-PCR and Q-PCR 
showed that CD4-TLR4 transgenic mice express the transgene throughout the gut as early as 
4 weeks of age (Figure S1A), with highest expression levels occurring predominantly in the 
proximal small intestine and colon (Figure S1B). Immunostaining of intestinal sections with 
anti-mouse CD4 antibody verified epithelial localization of the fusion protein in transgenic 
but not in control mice (Figure S1C). The CD4-TLR4 mice had normal lifespan and did not 
exhibit abnormalities in intestinal morphology or abnormal influx of inflammatory cells 
(Figure S1D). Thus constitutive TLR4 signalling in intestinal epithelia does not induce 
spontaneous inflammation nor affect intestinal function and morphology.  
We next crossed CD4-TLR4 mice with APCMin/+ mice, and analyzed for tumor load in 
the intestines of these mice. Unexpectedly, we found that APCMin/+ mice expressing 
constitutively active TLR4 developed significantly fewer tumors in small intestine than 
APCMin/+ mice at both 16- and 28- weeks of age (P= 5.432e-05 and P= 0.0023 respectively, 
Mann-Whitney) (Figure 1A and S2A). Mean tumor size was also significantly reduced in 
these mice as compared to age-matched APCMin/+ mice at 16 weeks of age (P= 1.881e-12, 
Mann-Whitney test) (Figure 1B).  
   
Transgene expression enhances Paneth cell functions leading to increased epithelial 
growth in long-term ex vivo cultures.  
 As we were surprised by the dramatic reduction of tumor load in CD4-TLR4-
APCMin/+ mice, we examined whether long-term, in vivo, epithelial TLR4 stimulation 
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influenced intestinal epithelial proliferation. Immunohistochemical analysis of Ki-67 revealed 
increased nuclear staining in intestinal epithelial cells residing above crypt bases of CD4-
TLR4 mice as compared to WT mice (Figure 2A), indicating a higher proliferative status of 
the intestinal epithelium during persistent TLR4 activation.  
We then sought to investigate how constitutive epithelial TLR4 signalling can 
influence the stem cell compartment, thus impacting on epithelial proliferation. As Paneth 
cells have been demonstrated to be critical for the maintenance and ability of Lgr5+ intestinal 
stem cells to form self-organizing crypt-villus organoids through producing essential niche 
signals [26], we checked our CD4-TLR4 mice for Paneth cell functions. Periodic acid-Schiff 
(PAS) staining of intestinal segments of WT and CD4-TLR4 mice showed more abundant 
staining of Paneth cell-like cells at colonic crypt bases as well as goblet cells at colonic crypts 
of CD4-TLR4 mice as compared to age-matched, WT counterparts (Figure S3, upper panel). 
In contrast, we did not detect visible differences in Paneth cells and goblet cells amounts in 
the small intestines of CD4-TLR4 and WT mice (Figure S3, lower panel).  
Consistent with increased Paneth cell levels, CD4-TLR4 mice expressed elevated 
mRNA expression of antimicrobial peptides, cryptdin-1 and lysozyme, in colonic mucosal 
scrapings as compared to WT mice and this was correlated with high expression levels of the 
transgene (>8-fold induction compared to lowest transgene expressing sample) (P<0.01, 
Mann-Whitney) (Figure 2B). Similar observations were found for relative expression levels 
of Wnt1 and Wnt3, which are known to be produced by Paneth cells [27] (P<0.01, Mann-
Whitney) (Figure 2B). The expression levels of proliferating cell nuclear antigen (PCNA) 
between WT and CD4-TLR4 colonic mucosal scrapings were however not significantly 
different (Figure 2B).  
To more precisely examine whether increased Paneth cell activity and persistent 
TLR4 stimulation had a proliferative impact on the intestinal epithelium, we purified 
intestinal crypts from CD4-TLR4 and WT mice and cultured them ex vivo for 5 days using an 
established matrigel-based culture system [26]. As regions S1-3 of the small intestines of 
CD4-TLR4 mice were found to express the highest levels of transgene (Figure S1B), we used 
the S1-3 intestinal segments from both CD4-TLR4 and WT mice for our crypt isolation 
studies. We found that while the ability to form viable crypt-villus organoids a day after 
initial plating did not differ between CD4-TLR4 and WT intestinal crypts, CD4-TLR4 
organoids appeared to be larger and more viable than WT organoids after 5 days of culture, 
forming new crypts from budding sites (Figure 3A). Moreover, Ki-67 staining showed denser 
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nuclear staining in the villus regions of CD4-TLR4 organoids as compared to WT organoids 
(Figure 3B).  
We further performed real-time PCR expression analyses of our crypt-villus organoid 
cultures after 5 days and observed that CD4-TLR4 organoids maintained elevated levels of 
Paneth cell markers - cryptdin-1, lysozyme and Wnt3 in comparison to WT organoids (Figure 
3C), similar to our earlier findings from mucosa scrapings (Figure 2B). Interestingly, a strong 
induction of Lgr5 and PCNA was observed in CD4-TLR4 organoids as compared to WT 
organoids (Figure 3C), which is consistent with the current notion that increased Paneth cell 
levels promote the maintenance and development of intestinal stem cells, as well as epithelial 
cell growth.  
We then asked whether increased Paneth cell activity in CD4-TLR4 organoids was 
due to constitutive TLR4 stimulation in Paneth cells by performing FACS sorting of CD24+ 
Paneth cells from purified intestinal crypts of CD4-TLR4 mice and probing for transgene 
expression in sorted Paneth cells. As shown in Figure S4, sorted CD24high cells (P8 fraction) 
were found to express elevated levels of Paneth cell markers – cryptdin-1, lysozyme and 
defcr-rs-10 as compared to CD24low cells (P5 and P6 fractions). Notably, sorted CD24high 
Paneth cells expressed higher levels of transgene than CD24low cells (Figure S4B). Taken 
together, our findings demonstrate that constitutive TLR4 signalling in the intestinal 
epithelium drives epithelial cell proliferation through enhanced Paneth cell functions in vivo. 
Moreover, CD4-TLR4 organoids expressed higher levels of chromogranin A (CHGA) and 
mucin 2 (Muc2) which are known markers of enteroendocrine and goblet cells respectively 
(Figure 3C), demonstrating that persistent epithelial TLR4 activation leads to enhanced 
functions of all secretory lineages in the intestine.  
 
Reduced Cox-2 expression correlates with increased apoptosis levels of CD4-TLR4 
expressing intestinal tumors 
While we observed that increased proliferation in our ex vivo organoid cultures is 
correlated with active TLR4 signalling, we were surprised to find reduced Cox-2 levels in 
CD4-TLR4 organoids after 5 days of culture (Figure 3C). As Cox-2 is an important player of 
tumorigenesis [28, 29, 30], we investigated levels of transgene and Cox-2 in small intestinal 
tumors of CD4-TLR4-APCMin/+ mice. Subsequent real-time pcr analyses revealed an inverse 
correlation between transgene expression and Cox-2 levels in CD4-TLR4-APCMin/+ tumors 
(Figure 4A). Notably, Cox-2 expression was significantly reduced in CD4-TLR4-APCMin/+ 
tumors as compared to tumors from age-matched APCMin/+ mice (Figure 4B; P<0.01, Mann-
11 
 
Whitney), consistent with lower protein levels of Cox-2 in tumor lysates (Figure S5). This 
down-regulation of Cox-2 expression correlated with an increased expression of pro-
apoptotic markers, Bad and p21 (Figure 4C). Interestingly, IFNβ1, a type I interferon (IFN) 
found to contribute positively to antitumoral immune responses in TLR4-activated tumors 
[31], was markedly up-regulated (10-fold increase) in CD4-TLR4-APCMin/+ tumors as 
compared to APCMin/+ tumors (Figure 4B; P<0.001, MannWhitney). Subsequent analysis of 
these tumors for markers of proliferation and various secretory cell lineages showed that 
despite an increased expression of Wnt3 in CD4-TLR4-APCMin/+ tumors, expression levels of 
PCNA and Paneth cell markers, cryptdin-1 and lysozyme, were not different from that of 
APCMin/+ tumors (Figure 4D). Meanwhile, increased Muc2 expression was observed in CD4-
TLR4-APCMin/+ tumors while CHGA levels remained unchanged (Figure 4D). 
As Cox-2 is known to be an important mediator of tumor cell survival through the 
inhibition of apoptosis [13, 14], we probed whether Cox-2 down-regulation in CD4-TLR4 
expressing mice increased levels of apoptosis in normal and transformed epithelial cells in 
vivo. We injected WT and CD4-TLR4 mice, as well as APCMin/+ and transgene-expressing 
APCMin/+ mice with FAM-FLIVO, a green fluorescent probe (carboxyfluorescein) that binds 
irreversibly to active caspases [32], and analyzed for levels of apoptotic cells in normal 
mucosa and tumor tissues of the small intestine. We found that while small intestinal tumors 
did not appear histologically different between WT and CD4-TLR4-expressing APCMin/+ 
mice (Figure 5A), levels of apoptotic cells in CD4-TLR4-APCMin/+ tumors were markedly 
higher than age-matched, non-transgenic APCMin/+ mice (Figure 5B and 5C; P<0.001, Mann-
Whitney). In contrast, no significant differences in levels of apoptotic cells were observed in 
the normal mucosa of CD4-TLR4 mice as compared to age-matched WT mice (Figure S6). 
Collectively, these findings thus demonstrate an elevated level of apoptosis in CD4-TLR4-
expressing intestinal tumor cells in vivo, that correlate with Cox-2 down-regulation. 
 
Discussion 
 The interaction of commensal microflora with the host via TLR signalling is critical 
not only for host defense against pathogens, but also for gut epithelial homeostasis such as 
the maintenance of a healthy epithelial barrier and regulation of epithelial cell proliferation. 
Thus in our study, we employed constitutively active TLR4 as an experimental approach to 
simulate host-microbe signalling in vivo and in turn understand its role in regulating epithelial 
homeostasis and tumorigenesis. Through introduction of epithelial CD4-TLR4 in the 
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APCMin/+ mouse model of intestinal tumorigenesis, our findings reveal the intricate balance 
between epithelial proliferation and apoptosis that is regulated by microbial signalling. This 
fine equilibrium of proliferation versus programmed cell death modulates aberrant epithelial 
cell growth and hence the development of intestinal tumors. 
In our study, we found that persistent epithelial TLR4 activation impacts on Paneth 
cell functions, as well as all other secretory cell lineages in the intestine, thus regulating 
epithelial cell growth and intestinal homeostasis. While constitutive TLR4 signalling results 
in an increased proliferative status of the intestinal epithelium, a higher extent of apoptosis 
also ensues in a genetically predisposed environment, possibly through down-regulation of 
critical survival factor, Cox-2. Thus as an indirect consequence of constitutive TLR4 
signalling, the turnover rate of transformed intestinal epithelial cells is enhanced and this 
disrupted balance of proliferation versus apoptosis tips over towards the latter, leading to the 
suppression of APCMin/+-driven spontaneous tumorigenesis.  
Using the APCMin/+ mouse model of spontaneous intestinal tumorigenesis, we found 
that the expression of constitutively active TLR4 in intestinal epithelium results in the 
suppression of intestinal tumor outgrowth (Figure 1 and S2A). Although mice transgenic for 
CD4-TLR4 in the intestinal epithelium i.e. villin-TLR4 mice have been studied previously in 
a colitis-associated neoplasia model [33], we used a different promoter, the intestinal fatty 
acid binding protein (I-FABP) promoter, which is only activated when differentiating 
enterocytes leave the crypts and migrate to the base of small intestinal villi or surface of 
colonic epithelia [24, 25]. As such, in contrast to the villin promoter, I-FABP promoter 
circumvents interference of the active transgene with stem cell development and early 
differentiation of the four epithelial lineages at intestinal crypt bases. Thus, we verified 
transgene expression and their epithelial localization in the intestine of these mice (Figure 
S2A-C).  
While we were surprised to find a remarkable reduction of tumor burden in CD4-
TLR4-expressing APCMin/+ mice (Figure 1 and S3A), our data from intestinal mucosal tissues 
and ex vivo organoid cultures support current, cumulative evidence for the major contribution 
of TLR4 signalling in epithelial cell proliferation [3, 4, 17, 18]. Notably, we found that 
constitutively active epithelial TLR4 resulted in increased proliferating cells (Figure 2A) 
correlating with increased Paneth cells (Figure S3) and elevated expression of Paneth cell 
markers (cryptdin-1 and lysozyme) and Wnts in the intestine (Figure 2B). This increased 
proliferative status was further recapitulated in our ex vivo organoid cultures (Figure 3). 
Meanwhile, this increased proliferative capacity did not result in aberrant crypt outgrowth in 
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the transgenic mice (Figure S1D), suggesting that additional regulatory signals, such as 
enhanced functions of all secretory cell lineages (Figure 3C), are in place to prevent aberrant 
epithelial growth and maintain normal intestinal homeostasis.  
Although a recent study has shown that Lgr5+ intestinal stem cells can function 
normally in the absence of Paneth cells [34], our studies support accumulating evidence for 
the major contribution of Paneth cells in intestinal stem cell survival and self renewal 
functions [26, 35]. Moreover, the identification of transgene expression in FACS-sorted 
Paneth cells from purified CD4-TLR4 expressing crypts, coupled with our ex vivo organoid 
cultures, suggest the role of active TLR4 signalling in stimulating Paneth cell activity and 
thus intestinal epithelial proliferation.  However, we do not rule out the possibility that Paneth 
cells are not the sole producers of essential niche signals for Lrg5 stem cells.  
While we observed proliferative effects associated with active TLR4 stimulation, one 
intriguing finding arising from our ex vivo organoids culture work was the regulation of 
TLR4 on Cox-2 expression. Although current cumulative evidence support the notion that 
TLR4 induces Cox-2 expression in both intestinal epithelial cells and lamina propria stromal 
cells as an important homeostatic response triggered during inflammatory stimulation [36, 
37], our study suggests that chronic stimulation of TLR4 in intestinal epithelial cells may lead 
to the downregulation of Cox-2 instead (Figure 3C).  
This interesting phenomenon provides a plausible mechanism underlying the reduced 
tumor load observed in our CD4-TLR4-APCMin/+ mice (Figure 1 and S2A). We found 
significantly reduced levels of Cox-2 expression in intestinal tumors from CD4-TLR4-
APCMin/+ mice as compared to tumors from APCMin/+ mice, which correlated with high 
transgene expression (Figure 4A-B and S5). This finding thus supports the role of Cox-2 
inhibitors in the amelioration of intestinal tumors in APCMin/+ mice as well as in familial 
adenomatous polyposis (FAP) patients [15, 16]. Moreover, other epithelial models of Cox-2 
overexpression using both cancer cell lines and transgenic mice have demonstrated the role of 
Cox-2 in promoting tumor development [38, 39].  
Accumulating evidence has pointed to the significant contribution of Cox-2 in tumor 
promotion by imparting resistance to apoptosis [13, 14]. One study has also reported that 
mice expressing the CD4-TLR4 construct under a different epithelial promoter developed 
significantly more azoxymethane (AOM)-induced tumors when mucosal Cox-2 levels were 
significantly up-regulated by repeated cycles of DSS-induced colitis [21]. In contrast, our in 
vivo studies of CD4-TLR4-APCMin/+ mice support the role of Cox-2 in the regulation of 
apoptosis when mere TLR4 activation in epithelial cells is not supported by concomitant 
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inflammation. Notably, the down-regulation of Cox-2 in CD4-TLR4 expressing intestinal 
tumors was closely associated with an increased expression of apoptotic markers –Bad and 
p21 (Figure 4C). This increased apoptotic potential was further highlighted in vivo by a 
marked increase in apoptotic cells per tumor area in the small intestinal tumors of CD4-
TLR4-APCMin/+ mice (Figure 5B-C), thereby suggesting that Cox-2 inhibition promotes the 
apoptosis of intestinal epithelial cells leading to decreased survival of CD4-TLR4-APCMin/+ 
tumors.  
Interestingly, the expression of IFNβ1, a key host defense cytokine against pathogens 
including microbes and tumor cells, is also upregulated in these CD4-TLR4 tumors (Figure 
4B). While IFNβ has been recently identified to be produced by TLR4-activated tumor cells 
as a critical mediator of the antitumoral immune response [31], the synergistic effect of Cox-
2 inhibitor and IFNβ in the induction of apoptosis has been demonstrated previously to be 
efficacious in tumor cell lines and xenotransplanted tumors [40]. Moreover, IFNβ has been 
shown to inhibit Cox-2 expression at the transcriptional level in intestinal epithelial cells [41]. 
These findings thus provide a possible mechanism for the increased levels of apoptotic cells 
detected in CD4-TLR4 tumors, resulting in the overall suppression of intestinal 
tumorigenesis. This reduced tumor burden of CD4-TLR4-APCMin/+ mice was in spite of 
enhanced mucosal expression of growth factors (Wnts), and Paneth cell functions which 
supports epithelial cell proliferation. These observations thus put forth an interesting notion 
that chronic TLR4 activation counteracts growth signals in the intestinal epithelium through 
triggering apoptosis, which in turn influences tumor initiation and survival, and this is likely 
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Figure 1. Constitutive TLR4 signalling in intestinal epithelium inhibits APCMin/+-driven 
intestinal tumorigenesis. (A) CD4-TLR4-APCMin/+ mice (n=11) have reduced tumor load in 
both colon (right panel, asterisk represent P<0.05, Fisher’s test) and small intestine (left 
panel, asterisk represent P<0.05, Mann-Whitney) at 16 weeks of age as compared to age-
matched APCMin/+ mice (n=12). (B) Distribution of tumor sizes and counts in CD4-TLR4-
APCMin/+ mice and APCMin/+ mice at 16 weeks of age (asterisk represent P<0.01, Mann-
Whitney, n=105 and n=435 for small intestinal tumors derived from CD4-TLR4-APCMin/+ 
and APCMin/+ mice respectively. 
Figure 2. Transgene expression in intestinal epithelium leads to increased epithelial cell 
proliferation and enhanced Paneth cell functions. (A) Ki-67 staining of colon and small 
intestine of age-matched CD4-TLR4 and WT mice. (B) Relative expression levels of Paneth 
cell markers (Wnt1, Wnt3, cryptdin-1 and lysozyme) and PCNA in colonic mucosal 
scrapings of CD4-TLR4 (n=18) and WT mice (n=8) were analyzed by qRT-PCR. CD4-TLR4 
samples were further categorized according to levels of transgene expression: CD4-TLR4 
low (relative fold change 1-8) (n=9) and CD4-TLR4 high (relative fold change >8) (n=9). All 
asterisks represent P<0.01, Mann-Whitney test.  
 
Figure 3. Transgene expression in intestinal epithelium results in enhanced functions of all 
secretory cell lineages and promotes epithelial cell proliferation ex vivo. (A) Representative 
pictures of ex vivo intestinal crypt organoid cultures of CD4-TLR4 (lower panels) and WT 
(upper panels) mice following one and five days of plating as indicated. (B) CD4-TLR4 
organoids (right column) display more abundant Ki-67 nuclear staining than WT (left 
column) organoids. (C) CD4-TLR4 organoids express elevated levels of markers for Paneth 
cells (Wnt3, cryptdin-1 and lysozyme), proliferation (PCNA), intestinal stem cells (Lrg5), 
enteroendocrine cells (CHGA) and goblet cells (Muc2) while Cox-2 expression in down-
regulated in comparison to WT organoids. Graphs represent datasets from one out of 3 
independent experiments. 
 
Figure 4. CD4-TLR4-expressing APCMin/+ tumors have reduced Cox-2 expression which 
correlates with increased levels of apoptotic markers. (A) Inverse correlation between 
transgene expression and Cox-2 levels in intestinal tumors from CD4-TLR4-APCMin/+ mice 
(n=8). (B) Transgene-expressing intestinal tumors from CD4-TLR4-APCMin/+ mice (n=8) 
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have reduced Cox-2 levels and increased IFNβ1 expression than tumors from APCMin/+ mice 
(n=8). Asterisks represent P<0.01 and P<0.001 respectively, Mann-Whitney test. (C) 
Intestinal tumors from CD4-TLR4-APCMin/+ mice expressing low Cox-2 levels display 
increased expression of apoptotic markers, Bad and p21, as compared to tumors from 
APCMin/+ mice. (D) Relative expression levels of proliferation- and various secretory cell 
lineage markers in small intestinal tumors from APCMin/+ (n=8) and CD4-TLR4-APCMin/+ 
mice (n=8). Asterisks represent P<0.01 and P<0.1 for Wnt3 and Muc2 respectively, Mann-
Whitney test. 
 
Figure 5. CD4-TLR4-APCMin/+ mice display increased apoptosis in normal and transformed 
epithelial cells. (A) H&E staining of small intestinal tumors from CD4-TLR4-APCMin/+ and 
APCMin/+ mice. (B) Representative images of in vivo labelled apoptotic cells (green) in small 
intestinal tumors of APCMin/+ and CD4-TLR4-APCMin/+ mice. (C) Counts of apoptotic 
epithelial cells per small intestinal tumor area of CD4-TLR4-APCMin/+ versus APCMin/+ mice. 





1 Rakoff-Nahoum S, Medzhitov R. Regulation of Spontaneous Intestinal Tumorigenesis 
Through the Adaptor Protein MyD88. Science 2007;317:124-7. 
2 Luo J-L, Maeda S, Hsu L-C, et al. Inhibition of NF-ĸ B in cancer cells converts inflammation- 
induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression. Cancer Cell 
2004;6:297-305. 
3 Pidgeon GP, Harmey JH, Kay E, et al. The role of endotoxin/lipopolysaccharide in surgically 
induced tumour growth in a murine model of metastatic disease. Br J Cancer 1999;81:1311-7. 
4 Harmey JH, Bucana CD, Lu W, et al. Lipopolysaccharide-induced metastatic growth is 
associated with increased angiogenesis, vascular permeability and tumor cell invasion. International 
Journal of Cancer 2002;101:415-22. 
5 Chicoine M, Zahner M, Won E, et al. The in vivo antitumoral effects of lipopolysaccharide 
against glioblastoma multiforme are mediated in part by Toll-like receptor 4. Neurosurgery 
2007;60:372-80. 
6 Andreani V, Gatti G, Simonella L, et al. Activation of Toll-like Receptor 4 on Tumor Cells In 
vitro Inhibits Subsequent Tumor Growth In vivo. Cancer Research 2007;67:10519-27. 
7 Maehara Y, Okuyama T, Kakeji Y, et al. Postoperative immunochemotherapy including 
streptococcal lysate OK-432 is effective for patients with gastric cancer and serosal invasion. The 
American Journal of Surgery 1994;168:36-40. 
8 Sato M, Harada K, Yoshida H, et al. Therapy for oral squamous cell carcinoma by tegafur and 
streptococcal agent OK-432 in combination with radiotherapy: association of the therapeutic effect 
with differentiation and apoptosis in the cancer cells. Apoptosis 1997;2:227-38. 
9 Otto F, Schmid P, Mackensen A, et al. Phase II trial of intravenous endotoxin in patients with 
colorectal and non-small cell lung cancer. European Journal of Cancer 1996;32A:1712-8. 
10 Razack AHA. Bacillus Calmette–Guérin and Bladder Cancer. Asian Journal of Surgery 
2007;30:302-9. 
11 Garay RP, Viens P, Bauer J, et al. Cancer relapse under chemotherapy: Why TLR2/4 receptor 
agonists can help. European Journal of Pharmacology 2007;563:1-17. 
12 Smith WL, DeWitt DL, Garavito RM. CYCLOOXYGENASES: Structural, Cellular, and Molecular 
Biology. Annual Review of Biochemistry 2000;69:145-82. 
13 Trifan OC, Hla T. Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis. 
Journal of Cellular and Molecular Medicine 2003;7:207-22. 
14 Wang D, DuBois RN. Prostaglandins and cancer. Gut 2006;55:115-22. 
15 Steinbach G, Lynch PM, Phillips RKS, et al. The Effect of Celecoxib, a Cyclooxygenase-2 
Inhibitor, in Familial Adenomatous Polyposis. New England Journal of Medicine 2000;342:1946-52. 
16 Swamy MV, Patlolla JMR, Steele VE, et al. Chemoprevention of Familial Adenomatous 
Polyposis by Low Doses of Atorvastatin and Celecoxib Given Individually and in Combination to 
APCMin Mice. Cancer Research 2006;66:7370-7. 
17 Li Y, Kundu P, Seow SW, et al. Gut Microbiota accelerate Tumor Growth via c-Jun and STAT3 
Phosphorylation in APCMin/+ Mice. . Carcinogenesis 2012. 
18 Yokota S-i, Okabayashi T, Rehli M, et al. Helicobacter pylori Lipopolysaccharides Upregulate 
Toll-Like Receptor 4 Expression and Proliferation of Gastric Epithelial Cells via the MEK1/2-ERK1/2 
Mitogen-Activated Protein Kinase Pathway. Infection and Immunity 2010;78:468-76. 
19 Bohnhorst J, Rasmussen T, Moen SH, et al. Toll-like receptors mediate proliferation and 
survival of multiple myeloma cells. Leukemia 2006;20:1138-44. 
20 Moser A, Pitot H, Dove W. A dominant mutation that predisposes to multiple intestinal 
neoplasia in the mouse. Science 1990;247:322-4. 
21 Medzhitov R, Preston-Hurlburt P, Janeway CA. A human homologue of the Drosophila Toll 
protein signals activation of adaptive immunity. Nature 1997;388:394-7. 
19 
 
22 Arulampalam V, Grant PA, Samuelsson A, et al. Lipopolysaccharide-dependent 
transactivation of the temporally regulated immunoglobulin heavy chain 3′ enhancer. European 
Journal of Immunology 1994;24:1671-7. 
23 Sato T, Vries RG, Snippert HJ, et al. Single Lgr5 stem cells build cryptÂ–villus structures in 
vitro without a mesenchymal niche. Nature 2009;459:262-5. 
24 Cohn SM, Simon TC, Roth KA, et al. Use of transgenic mice to map cis-acting elements in the 
intestinal fatty acid binding protein gene (Fabpi) that control its cell lineage-specific and regional 
patterns of expression along the duodenal-colonic and crypt-villus axes of the gut epithelium. The 
Journal of Cell Biology 1992;119:27-44. 
25 Sweetser D, Hauft S, Hoppe P, et al. Transgenic mice containing intestinal fatty acid-binding 
protein-human growth hormone fusion genes exhibit correct regional and cell-specific expression of 
the reporter gene in their small intestine. Proc Natl Acad Sci U S A 1988;85:9611-5. 
26 Sato T, van Es JH, Snippert HJ, et al. Paneth cells constitute the niche for Lgr5 stem cells in 
intestinal crypts. Nature 2011;469:415-8. 
27 Gregorieff A, Pinto D, Begthel H, et al. Expression Pattern of Wnt Signaling Components in 
the Adult Intestine. Gastroenterology 2005;129:626-38. 
28 Kargman SL, O'Neill GP, Vickers PJ, et al. Expression of Prostaglandin G/H Synthase-1 and -2 
Protein in Human Colon Cancer. Cancer Research 1995;55:2556-9. 
29 Kutchera W, Jones DA, Matsunami N, et al. Prostaglandin H synthase 2 is expressed 
abnormally in human colon cancer: evidence for a transcriptional effect. Proceedings of the National 
Academy of Sciences 1996;93:4816-20. 
30 Sheng H, Shao J, Kirkland SC, et al. Inhibition of human colon cancer cell growth by selective 
inhibition of cyclooxygenase-2. The Journal of Clinical Investigation 1997;99:2254-9. 
31 Núňez NG, Andreani V, Crespo MI, et al. IFNβ Produced by TLR4-Activated Tumor Cells Is 
Involved in Improving the Antitumoral Immune Response. Cancer Research 2011;72:592-603. 
32 Cursio R, Colosetti P, Auberger P, et al. Liver Apoptosis Following Normothermic Ischemia-
Reperfusion: In Vivo Evaluation of Caspase Activity by FLIVO Assay in Rats. Transplantation 
Proceedings 2008;40:2038-41. 
33 Fukata M, Shang L, Santaolalla R, et al. Constitutive activation of epithelial TLR4 augments 
inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis. Inflammatory 
Bowel Diseases 2011;17:1464-73. 
34 Kim T-H, Escudero S, Shivdasani RA. Intact function of Lgr5 receptor-expressing intestinal 
stem cells in the absence of Paneth cells. Proceedings of the National Academy of Sciences 
2012;109:3932-7. 
35 Rothenberg ME, Nusse Y, Kalisky T, et al. Identification of a cKit+ Colonic Crypt Base 
Secretory Cell That Supports Lgr5+ Stem Cells in Mice. Gastroenterology 2012. 
36 Fukata M, Chen A, Klepper A, et al. Cox-2 Is Regulated by Toll-Like Receptor-4 (TLR4) 
Signaling: Role in Proliferation and Apoptosis in the Intestine. Gastroenterology 2006;131:862-77. 
37 Brown SL, Riehl TE, Walker MR, et al. Myd88-dependent positioning of Ptgs2-expressing 
stromal cells maintains colonic epithelial proliferation during injury. The Journal of Clinical 
Investigation 2007;117:258-69. 
38 Singh B, Berry JA, Shoher A, et al. COX-2 overexpression increases motility and invasion of 
breast cancer cells. International Journal of Oncology 2005;26:1393-9. 
39 Müller-Decker K, Neufang G, Berger I, et al. Transgenic cyclooxygenase-2 overexpression 
sensitizes mouse skin for carcinogenesis. Proceedings of the National Academy of Sciences 
2002;99:12483-8. 
40 Nakamoto N, Higuchi H, Kanamori H, et al. Cyclooxygenase-2 inhibitor and interferon-β 




41 Klampfer L, Huang J, Kaler P, et al. STAT1-independent inhibition of cyclooxygenase-2 
expression by IFNγ; a common pathway of IFNγ-mediated gene repression but not gene activation. 
Oncogene 2007;26:2071-81. 
 
 
 
